| Literature DB >> 27524612 |
Kipyegon Kitur1, Sarah Wachtel2, Armand Brown2, Matthew Wickersham2, Franklin Paulino2, Hernán F Peñaloza3, Grace Soong2, Susan Bueno3, Dane Parker2, Alice Prince4.
Abstract
Staphylococcus aureus triggers inflammation through inflammasome activation and recruitment of neutrophils, responses that are critical for pathogen clearance but are associated with substantial tissue damage. We postulated that necroptosis, cell death mediated by the RIPK1/RIPK3/MLKL pathway, would function to limit pathological inflammation. In models of skin infection or sepsis, Mlkl-/- mice had high bacterial loads, an inability to limit interleukin-1b (IL-1b) production, and excessive inflammation. Similarly, mice treated with RIPK1 or RIPK3 inhibitors had increased bacterial loads in a model of sepsis. Ripk3-/- mice exhibited increased staphylococcal clearance and decreased inflammation in skin and systemic infection, due to direct effects of RIPK3 on IL-1b activation and apoptosis. In contrast to Casp1/4-/- mice with defective S. aureus killing, the poor outcomes of Mlkl-/- mice could not be attributed to impaired phagocytic function. We conclude that necroptotic cell death limits the pathological inflammation induced by S. aureus.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27524612 PMCID: PMC5001919 DOI: 10.1016/j.celrep.2016.07.039
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423